GENEVA, Nov. 5 /PRNewswire-FirstCall/ -- STMicroelectronics (NYSE: STM), one of the world's leading semiconductor companies, and Mayo Clinic, a premier health-care organization, are collaborating on a novel platform for remotely monitoring patients with chronic cardiovascular disease. The platform will provide a comprehensive and unobtrusive solution that monitors person-specific data and physiological parameters and influences lifestyle and treatment choices.
Telemedicine, which allows medical professionals to monitor or treat patients even when they are not in the same location, is widely recognized as an essential step in reducing the escalating cost of healthcare. Instead of entering a hospital or visiting a doctor for check-ups, the patient wears a small device that continually monitors a number of relevant physiological parameters. This approach has many potential benefits, including maintaining wellness, earlier detection of developing health conditions, improving lifestyle, and lowering healthcare costs.
"Mayo Clinic has always committed the best available resources to caring for patients with cardiovascular disease. This collaboration, by enhancing our ability to record important physiologic information while patients are outside the medical environment and active in their daily lives, will extend our ability to prevent and treat illness," said Paul Friedman, M.D., a cardiology consultant and specialist in cardiovascular electrophysiology at Mayo Clinic, who added that an initial program of patient trials is already underway.
This platform is the result of an R&D collaboration that combines ST's expertise in developing innovative solutions using its advanced sensor, microprocessor and communication products and Mayo Clinic's best-in-class medical expertise. It uses a combination of sensors, ultra-low-power microcontroller and wireless modules, and interfaces to provide information about the patient's heart rate, breathing rate, physical activity and other measurements wirelessly obtained from external medical devices.
"Combining the worldwide recognized clinical expertise of Mayo Clinic with our ability to provide highly integrated volume solutions at affordable costs, we are convinced we will open new frontiers to bring quality healthcare to everybody," said Alessandro Cremonesi, Vice President, Advanced System Technology, STMicroelectronics. "ST is utilizing its strong expertise to develop advanced technologies and products satisfying the requirements of telemedicine platforms. This will allow medical device manufacturers and health-care providers to develop new products and services to enhance the quality of medical support for their customers and patients."
Telemedicine is expected to play an increasingly important role in helping solve the growing costs of healthcare monitoring and delivery, especially in the context of an aging population. For example, in the USA, which spent over $2 trillion on healthcare in 2007 - nearly twice the average per-capita spending of other developed countries - the Congressional Budget Office estimates that, with current trends, by 2025 some 25% of the national economy will be tied up in healthcare.(1)
In addition to better service to the patient, the potential benefits of remote monitoring may include:
Remote monitoring thus offers important opportunities to reduce healthcare costs and enhance patients' quality of life.
Further description of the platform for remote monitoring is available at
About Mayo Clinic Office of Intellectual Property
Mayo Clinic has one of the most highly evolved intellectual property and technology commercialization efforts in academic medicine, with a 20 plus year history of supporting Mayo's mission. The Office of Intellectual Property at Mayo Clinic, serves as a bridge between discoveries and the marketplace. The Office works closely with Mayo physicians and scientists to evaluate and develop inventions, ideas and discoveries that have the potential to transform healthcare and generate income to support Mayo patient care, education and research. Mayo Clinic's Office of Intellectual Property has filed more than 2,400 patents resulting in over 600 active patent-licensing agreements with industry.
STMicroelectronics is a global leader serving customers across the spectrum of electronics applications with innovative semiconductor solutions. ST aims to be the undisputed leader in multimedia convergence and power applications leveraging its vast array of technologies, design expertise and combination of intellectual property portfolio, strategic partnerships and manufacturing strength. In 2008, the Company's net revenues were $9.84 billion. Further information on ST can be found at www.st.com.
Note for editors
Neither Mayo Clinic nor its investigators will receive any payment for the use of products developed via this collaboration in clinical trials with Mayo Clinic patients.
Copyright©2009 PR Newswire.
All rights reserved